Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 11/20 | 0.52 |
| ▸ | CNR1 | P21554 | 3/20 | 0.51 |
| ▸ | THRA | P10827 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.45 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.42 |
| ▸ | BID | P55957 | 3/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.42 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25222846 | 0.86 | CNR2 (0.53) | CNR2CNR1LIPGBIDMCL1 | |
| SCHEMBL5495860 | 0.86 | CNR2 (0.53) | CNR2CNR1LIPGBIDMCL1 | |
| SCHEMBL28280851 | 0.84 | CNR2 (0.54) | CNR2CNR1BIDMCL1BCL2L1 | |
| SCHEMBL11522774 | 0.84 | CNR2 (0.51) | CNR2CNR1LIPGOXER1BID | |
| SCHEMBL17037749 | 0.82 | CNR2 (0.49) | CNR2CNR1 | |
| SCHEMBL11779245 | 0.82 | LIPG (0.57) | CNR2LIPGBIDMCL1BCL2L1 | |
| SCHEMBL30537736 | 0.82 | LIPG (0.57) | CNR2LIPGBIDMCL1BCL2L1 | |
| SCHEMBL6684013 | 0.81 | LIPG (0.54) | THRATHRBLIPGBIDMCL1 | |
| SCHEMBL6683967 | 0.81 | LIPG (0.54) | THRATHRBLIPGBIDMCL1 | |
| SCHEMBL8901188 | 0.81 | LIPG (0.54) | THRATHRBLIPGBIDMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4173616-A | COMPLEXING WITH HYDROXY-OXIME COMPOUNDS | SHELL OIL COMPANY (US) | 1979-11-06 | — | — | US | disclosed |